APIMEDS PHARMACEUTICALS US, INC. Depreciation
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Depreciation of $4.66 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- APIMEDS PHARMACEUTICALS US, INC. depreciation for the quarter ending 2026-06-30 was $4.66K, a 1909.48% increase year-over-year.
- APIMEDS PHARMACEUTICALS US, INC. depreciation for the quarter ending 2026-03-31 was $20.04K.
- APIMEDS PHARMACEUTICALS US, INC. depreciation for the quarter ending 2025-12-31 was $3.98K.
- APIMEDS PHARMACEUTICALS US, INC. depreciation for the quarter ending 2025-09-30 was $1.49K.
- APIMEDS PHARMACEUTICALS US, INC. depreciation for fiscal 2025 was $5.71K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.66K 10-Q · filed 2026-08-14 | $9.09K 10-Q · filed 2026-08-14 | $28.69K derived: sum of 3 quarters · filed 2026-08-14 | $30.18K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $20.04K 10-Q · filed 2026-05-26 | $24.03K derived: sum of 2 quarters · filed 2026-05-26 | $25.52K derived: sum of 3 quarters · filed 2026-05-26 | $25.75K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $3.98K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-04 | $5.47K derived: sum of 2 quarters · filed 2026-05-04 | $5.71K derived: sum of 3 quarters · filed 2026-08-14 | $5.71K 10-K · filed 2026-05-04 |
| 2025-09-30 | $1.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.72K derived: sum of 2 quarters · filed 2026-08-14 | $1.72K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $232.00 10-Q · filed 2026-08-14 | $232.00 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |